Perinatal Use of Citrulline Rescues Hypertension in Adult Male Offspring Born to Pregnant Uremic Rats
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25031612 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von You-Lin Tain und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan. Hauptthemen laut MEDLINE: Hypertension, Pre-Eclampsia, Renal Insufficiency, Chronic, Autonomic Nervous System Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kaohsiung Chang Gung Memorial Hospital, Taiwan.
Abstract (Originalsprache)
The growing recognition of the association between maternal chronic kidney disease (CKD) and fetal programming highlights the increased vulnerability of hypertension in offspring. Potential mechanisms involve oxidative stress, dysbiosis in gut microbiota, and activation of the renin–angiotensin system (RAS). Our prior investigation showed that the administration of adenine to pregnant rats resulted in the development of CKD, ultimately causing hypertension in their adult offspring. Citrulline, known for enhancing nitric oxide (NO) production and possessing antioxidant and antihypertensive properties, was explored for its potential to reverse high blood pressure (BP) in offspring born to CKD dams. Male rat offspring, both from normal and adenine-induced CKD models, were randomly assigned to four groups (8 animals each): (1) control, (2) CKD, (3) citrulline-treated control rats, and (4) citrulline-treated CKD rats. Citrulline supplementation successfully reversed elevated BP in male progeny born to uremic mothers. The protective effects of perinatal citrulline supplementation were linked to an enhanced NO pathway, decreased expression of renal (pro)renin receptor, and changes in gut microbiota composition. Citrulline supplementation led to a reduction in the abundance of Monoglobus and Streptococcus genera and an increase in Agothobacterium Butyriciproducens. Citrulline’s ability to influence taxa associated with hypertension may be linked to its protective effects against maternal CKD-induced offspring hypertension. In conclusion, perinatal citrulline treatment increased NO availability and mitigated elevated BP in rat offspring from uremic mother rats.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan.
- Institute for Translational Research in Biomedicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan.
- College of Medicine, Chang Gung University, Taoyuan 330, Taiwan.
- Department of Seafood Science, National Kaohsiung University of Science and Technology, Kaohsiung 811, Taiwan.
- Institute of Environmental Toxin and Emerging-Contaminant, Cheng Shiu University, Kaohsiung 833, Taiwan.
- Center for Environmental Toxin and Emerging-Contaminant Research, Cheng Shiu University, Kaohsiung 833, Taiwan.
ORCID-Profile: You-Lin Tain, Chih-Yao Hou, Guo-Ping Chang-Chien, Chien-Ning Hsu
Förderung
- Kaohsiung Chang Gung Memorial Hospital, Taiwan
Zitieren
APA
Tain, Y. L., Hou, C. Y., Chang-Chien, G. P., Lin, S., & Hsu, C. N. (2024). Perinatal Use of Citrulline Rescues Hypertension in Adult Male Offspring Born to Pregnant Uremic Rats. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25031612
Vancouver
Tain YL, Hou CY, Chang-Chien GP, Lin S, Hsu CN. Perinatal Use of Citrulline Rescues Hypertension in Adult Male Offspring Born to Pregnant Uremic Rats. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25031612
BibTeX
@article{Tain2024,
author = {Tain, You-Lin and Hou, Chih-Yao and Chang-Chien, Guo-Ping and Lin, Sufan and Hsu, Chien-Ning},
title = {Perinatal Use of Citrulline Rescues Hypertension in Adult Male Offspring Born to Pregnant Uremic Rats},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25031612}
}
EUVIMED